Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that can treat all types of AML.

Research findings, strategies target the leading cause of Latino death With cancer still rising in the U.S. Latino population, leaders at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and national cancer experts have published an online book with innovative recommendations to reduce Latino cancer. The book, “Advancing the […]

  Lei Zheng, MD, PhD, executive director of the Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has been awarded a $500,000 Translational Science and Technology Acquisition and Retention (STARs) award from The University of Texas System to elevate his research into monitoring pancreatic tumor […]

This article is featured in the December 2024 issue of San Antonio Medicine Magazine. As the golden sun peeks over the Hill Country skyline, UT Health San Antonio Multispecialty and Research Hospital begins to stir with the promise of a new day. A physician-scientist steps purposefully through the sleek glass entrance into an atrium bathed […]

This year in the United States, it is projected that more than 2 million people will be diagnosed with cancer. Additionally, more than 600,000 people will die of the disease — an average of nearly 1,680 each day. The V Foundation for Cancer Research was founded in 1993 by ESPN and basketball coach Jim Valvano […]

World-renowned biochemist and expert on the roles of BRCA1 and BRCA 2 in DNA repair, Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and associate dean for research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently recognized as the 2024 recipient of the […]

The School of Dentistry earned the first National Institutes of Health grant under its new Center for Pain Therapeutics and Addiction Research, addressing pain in patients with head and neck carcinoma.

  Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and associate dean for research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is the latest recipient of the 2024 Basser Global Prize. A leading researcher in the field of DNA damage repair and cancer biology, Sung has been awarded the […]

Mays Cancer Center offers a survivorship program to patients to prevent cancer from reoccurring through interventions and surveillance to help them live well after treatment.

Learn about Mays Cancer Center’s cardio-oncology program and what cancer patients who have cardiovascular conditions can expect.